SRTS: Officer-director reports open-market share purchases

Rhea-AI Filing Summary

Sensus Healthcare (SRTS) officer and director Michael Sardano reported open‑market purchases on November 11, 2025.

He acquired 1,000 shares of common stock at $4.26 held directly. Additional purchases were reported for his spouse of 766 shares at $4.27 and 234 shares at $4.24. Following these transactions, Sardano held 117,839 shares directly. He disclaims beneficial ownership of his spouse’s shares. Sardano serves as President and General Counsel and is also a Director.

Insider Trade Summary

Net Buyer: 2,000 shares ($8,523)

Net Buy 3 txns

Insider Sardano Michael

Role PRESIDENT AND GENERAL COUNSEL

Bought 2,000 shs ($9K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,000	$4.26	$4K
Purchase	Common Stock	766	$4.27	$3K
Purchase	Common Stock	234	$4.24	$992.16

Holdings After Transaction: Common Stock — 117,839 shares (Direct); Common Stock — 118,605 shares (Indirect, spouse)

Footnotes (1)

1. [object Object]

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sardano Michael

(Last) (First) (Middle)

851 BROKEN SOUND PARKWAY NW

STE. 215

(Street)

BOCA RATON FL 33487

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sensus Healthcare, Inc. [ SRTS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	PRESIDENT AND GENERAL COUNSEL

3. Date of Earliest Transaction (Month/Day/Year)
11/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)
11/12/2025

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/11/2025		P		1,000	A	$4.26	117,839	D
Common Stock	11/11/2025		P		766	A	$4.27	118,605	I	spouse(1)
Common Stock	11/11/2025		P		234	A	$4.24	118,839	I	spouse(1)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Shares held by Mr. Sardano's spouse, as to which he disclaims beneficial ownership.

	/s/ Michael Sardano	11/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did SRTS report for Michael Sardano?

On November 11, 2025, he bought 1,000 shares at $4.26 directly, and his spouse purchased 766 at $4.27 and 234 at $4.24.

How many SRTS shares does Michael Sardano hold after the trades?

He directly held 117,839 shares following the reported transactions.

Does Michael Sardano claim ownership of his spouse’s SRTS shares?

No. He disclaims beneficial ownership of shares held by his spouse.

What roles does Michael Sardano hold at Sensus Healthcare (SRTS)?

He is President and General Counsel and also a Director.

What was the transaction type on the Form 4/A for SRTS?

Each reported entry is coded P, indicating an open‑market purchase.

When was the earliest transaction date reported for SRTS?

The earliest transaction date reported is November 11, 2025.